ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Complement-Activating DSA: Which Assay in Which Setting?

    C. Lawrence, M. Willicombe, P. Brookes, E. Santos-Nunez, C. Roufosse, A. Warrens, D. Taube

    Imperial College Renal & Transplant Centre, Hammersmith Hospital, London, United Kingdom

    The presence of pre-formed and de novo donor specific antibodies [DSA] are associated with an increased incidence of antibody mediated rejection [AMR] and graft loss…
  • 2013 American Transplant Congress

    Complement-Activating Low-Level Preformed Donor-Specific Antibodies Detected by C1qScreen™ Predict Early Antibody-Mediated Rejection in Renal Allografts

    C. Lawrence, M. Willicombe, P. Brookes, C. Clarke, E. Santos-Nunez, C. Roufosse, A. Warrens, D. Taube

    Imperial College Renal & Transplant Centre, Hammermsith Hospital, London, United Kingdom

    Renal transplant recipients with negative CDC [CDC-XM] and Flow crossmatch [Flow-XM] and low level DSA [by Luminex] have worse outcomes than non-sensitized patients. The aim…
  • 2013 American Transplant Congress

    In-Vivo Persistence, Trafficking and Phenotypic Stability of Autologous, Ex-Vivo Expanded Rhesus Macaque Natural Regulatory T Cells

    K. Singh, L. Stempora, A. Garrett, A. Kirk, C. Larsen, B. Blazar, L. Kean

    Emory Univ, Atlanta; Univ of Minnesota, Minneapolis

    Infusion of ex-vivo expanded natural regulatory T cells (Tregs) is emerging as a promising cellular therapy for the induction of allograft tolerance. However, the lack…
  • 2013 American Transplant Congress

    Liver Transplantation for Neonatal Hemochromatosis: Analysis of the UNOS Database

    S. Sheflin-Findling, R. Annunziato, R. Ragusa, J. Chu, N. Kerkar, R. Arnon

    Division of Pediatric Hepatology, Mount Sinai Medical Center, New York; Division of Pediatric Gastroenterology, Mount Sinai Medical Center, New York; Psychology Department, Fordham University, Bronx; Recanati/Miller Transplantation Institute, Mount Sinai Medical Center, New York

    Neonatal hemochromatosis (NH) is a rare condition of unclear etiology and remains the most common identifiable cause of acute liver failure in the neonate. Liver…
  • 2013 American Transplant Congress

    Renal Ischemia/Reperfusion Induces Release of Angiopoietin-2 from Human Grafts of Living and Deceased Donors

    M. Reinders, D. de Vries, M. Khairoun, J. Lindeman, I. Bajema, E. de Heer, M. Roest, A. van Zonneveld, C. van Kooten, A. Schaapherder, T. Rabelink

    Surgery, Leiden University Medical Center, Leiden, Netherlands; Nephrology, Leiden University Medical Center, Leiden, Netherlands; Pathology, Leiden University Medical Center, Leiden, Netherlands; Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, Netherlands

    Recent insights suggest that endothelial cell (EC) activation plays a major role in renal ischemia/reperfusion (I/R) injury. Interactions between ECs and pericytes via signaling molecules,…
  • 2013 American Transplant Congress

    Predictors of Combined Liver and Kidney Transplantation and Post-Transplant Liver Graft, Kidney Graft, and Patient Survival: Comparison to Patients Receiving Listed for Kidney but Receiving Liver Alone

    A. Singal, Y. Kuo, R. Wiesner, A. Singal

    Hepatology, UAB, Birmingham, AL; Biostatistics, UTMB, Galveston, TX; Hepatology, Mayo Clinic, Rochester, MN

    Background: Data on patient and liver kidney graft survival following combined liver kidney (CLK) transplantation remain conflicting. Aim: To compare outcomes after CLK transplantation to…
  • 2013 American Transplant Congress

    Factors Influencing Creatinine Rise Following Donor Nephrectomy

    D. Hale, D. Moore, X. Wu

    Kidney and Pancreas Transplantation, Vanderbilt University, Nashville, TN

    Introduction: Identifying factors influencing the rise in creatinine following donor nephrectomy will permit appropriate candidate selection and help ensure the long term safety of live…
  • 2013 American Transplant Congress

    Determinants of Geographic Variation in Access to Deceased Donor Kidney Transplantation for Children

    P. Reese, J. Hwang, V. Potluri, P. Abt, J. Shults, S. Amaral

    University of Pennsylvania, Philadelphia, PA; Children's Hosp of Philadelphia, Philadelphia, PA

    The OPTN prioritizes pediatric candidates (<18 years) in kidney allocation because children derive unique benefits from kidney transplant (KT). However, because allocation usually starts locally,…
  • 2013 American Transplant Congress

    Gender Disparity in Attitudes of Older Adults towards Kidney Transplantation

    R. Kamil, A. Law, M. McAdams-Demarco, D. Segev

    Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD

    Purpose: Elderly women with ESRD are significantly less likely than men of the same age and co-morbidities to be referred for kidney transplantation (KT), despite…
  • 2013 American Transplant Congress

    Insulin-Like Growth Factor-II (IGF-II) Prevents Pro-Inflammatory Cytokine Induced Apoptosis and Significantly Improves Islet Survival Post-Transplantation

    A. Hughes, D. Mohanasundaram, S. Kireta, C. Jessup, C. Drogemuller, P. Coates

    Renal Transplantation and Immunobiology Laboratory, The Royal Adelaide Hospital, Adelaide, South Australia, Australia; Australian Islet Transplant Consortium, Adelaide, South Australia, Australia; School of Medicine, University of Adelaide, Adelaide, South Australia, Australia; Department of Human Physiology, School of Medicine, Flinders University, Adelaide, South Australia, Australia; Centre for Stem Cell Research, University of Adelaide, Adelaide, South Australia, Australia

    Introduction: The early loss of functional islet mass (50-70%) due to apoptosis following clinical transplantation contributes to islet allograft failure. Insulin-like Growth Factor-II (IGF-II) is…
  • « Previous Page
  • 1
  • …
  • 1562
  • 1563
  • 1564
  • 1565
  • 1566
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences